中山大便疼中山便血医院地址,中山直肠镜检查,中山哪个医院看胃病好,中山上厕所便血是什么原因,中山大便带血 肛门疼痛,中山什么是高位肛瘘,中山女性便血有哪些危害呢

SAN DIEGO (KGTV) — Eve Ramirez made the difficult decision to close her City Heights taco shop when the coronavirus outbreak hit. She says she did it to protect her eight-month-old son. "I got scared to death," she said. "I was like, you know what, I had my baby boy in January, imagine something were to happen to me. I'm a single mom. I can't risk my baby's life. I immediately shut down without thinking twice."Ramirez, who owns Mexicali Street Tacos, is one of a large number of San Diegans now struggling to pay for basic necessities amid the pandemic. A San Diego Association of Governments study released Thursday says 71% of respondents reported not being able to pay for rent, food, and utilities, while two-thirds said the pandemic has negatively impacted their employment. Ramirez said she has received donated diapers from friends, is on Medi-Cal and is receiving government food allowances. "I had no choice but to apply for help," she said. More than 3,500 San Diego households responded to the survey, conducted via 23 community-based organizations. San Ysidro Health surveyed 300 families about the impact of the virus. Ana Melgoza, the organization's vice president of external affairs, says the virus has hit South Bay families particularly hard. She says many live in overcrowded homes due to high rent, and are forced to work in jobs that require interaction with the public such as in grocery stores and retail. "When you have people literally dying to go to work and provide for their families, we need to make sure health care is a priority for people so that when they do feel sick or are infected they have the right follow up care to manage and survive this deadly virus," Melgoza said. Melgoza said one potential solution is to provide hotel vouchers so people in overcrowded homes can quarantine safely. The study also says 60% of parents with school-aged children reported distance learning challenges during the school year. It calls for exploring new ways to provide direct monetary assistance to families in need, new partnerships between governments and community-based organizations, and new paid training and internship opportunities for underserved areas. 2201

SAN DIEGO (KGTV) - Fans and players on Petco Park's field fled as hundreds of bees swarmed near the Padres' dugout Sunday afternoon.At about 4:06 p.m., in the bottom of the 3rd inning, Fox Sports reported a queen bee landed on their microphone and hundreds of bees followed suit."It made my skin crawl," Padres Fan Kel Loftis said."Out of the blue all of the sudden you saw everybody running off the field," Padres Fan Bob Pollack said.As fans saw the area clear out, some were concerned for their family's safety, "it was kinda crazy like what's going on?" Loftis said. As a military man, he was concerned something more serious was happening.Then everyone in the stadium saw the television screens with a close up on the swarm. "Between [Austin] Hedges, [Josh] Naylor and [Glenn] Hoffman, you know the third base coach, I was wondering who was more panicked," Loftis said chuckling.Padres Catcher Austin Hedges was seen wearing a Deadpool mask, sweatshirt and holding two bats, seemingly ready to battle the bees. A man from Cartwright Pest Control came out to save the day. Fans dubbed him "Bee Man." The delay in total was less than 30 minutes.The Padres confirmed the company is out at the park for every game in case of an event like this.A group of Girl Scouts in the crowd were concerned about the safety of the bees. This isn't the first time Petco's had bees, a swarm showed up in July of 2009 and delayed the game by almost an hour.While fans thought the bee delay Sunday was strange, they took it in stride.Some parents used it as a teachable moment. "Well she had a lot of questions so the first thing she said was why are the bees out there?" Loftis said.The Padres confirmed they are equipped with EpiPens, as well as Benadryl in the event of an allergic reaction. There were no reports of anyone being stung. 1832

SAN DIEGO (KGTV) - For the first time since his arrest, the La Jolla restaurant owner charged with rape is speaking publicly. Daniel Dorado is testifying in his defense.Eight women have come forward saying Dorado drugged and sexually assaulted them over the course of a decade. The owner of the Voce del Mar restaurant in Birdrock faces 35 felony charges for allegedly raping women after drugging their drinks. RELATED: 8 women accuse Bird Rock restaurant owner of sexual assaultHe took the stand during trial Wednesday denying the drug allegations while saying each of the eight relationships were consensual. "She was interested in being alone with me," said Dorado. "She initiated the physical contact."Prosecutors say in at least two of the cases, a sexual relationship occurred after the women got visibly sick and threw up. RELATED: Trial begins for La Jolla restaurant owner accused of sexual assaults"I offered to have her husband pick her up at L'Auberge, she asked to sleep it off at my house," said Dorado. Police say Dorado met the victims on online dating sites and some of them under the guise of a job interview at a restaurant. He is scheduled to continue his testimony in court Thursday. 1213

SAN DIEGO (KGTV) — Horton Plaza's sale to real-estate firm Stockdale Capital Partners hopes to revitalize the plaza back to its former glory.10News reported the downtown shopping center was in escrow back in June. Now, plans for the site's future are being released, including a hub for mixed-use offices, retail, and restaurants, according to the firm's plans. It will also get a new name: The Campus at Horton.Stockdale plans to use the center to cater to the tech industry and entice technology companies to the area.RELATED: Grocery chain suing Horton Plaza over millions in sales losses"The Campus at Horton will be a thriving innovation hub, comprised of creative office space, captivating entertainment options, urban lifestyle retail choices and contemporary food and beverage experiences, catering to leading technology and biotechnology employers, locally and nationally," Steven Yari, Managing Director of Stockdale Capital, said.The project is expected to create 3,000 - 4,000 jobs and generate more than .8 billion in annual economic activity."We're ripe in downtown for an office explosion," said Gary London, senior principal of London Moeder Advisors, a commercial real estate analytics firm. "There's been a big movement in corporate American to marry the places where people work with the places where people live."A rendering of The Campus shows the project's bold re-imagining of Horton Plaza to create an office and retail campus, green space, and transform walkways into one boardwalk through the site.RELATED: Jessop's?Jewelry closing after 125 years in San DiegoThe firm added there will be an opportunity for additional construction to add 1.5 million square feet to the site."Our hope is that this project will serve as a catalyst for bringing high-tech tenants and thousands of jobs to downtown and spur other developments that will do the same," Ashley Gosal, Inhouse counsel for Bosa Development, said.Construction on the project is expected to begin in early 2019, while the project is slated for completion in fall 2020.A series of community workshops will be held with Stockdale, the San Diego Chamber of Commerce, and Regional Economic Development Corporation to discuss the plan and gather community feedback. 2268

SAN DIEGO (KGTV) — Governor Gavin Newsom’s vaccine safety task force will have to work quickly once the FDA announces a decision on Pfizer’s COVID-19 vaccine candidate.The 11-member panel, officially called the Scientific Safety Review Workgroup, has been tasked with reviewing the safety and efficacy of vaccine trials and rendering a recommendation on their use in California.The workgroup has a difficult mission: review the data thoroughly enough to offer a recommendation independent from the FDA, but do it fast enough to avoid delaying distribution of the vaccine.Pfizer’s emergency use authorization application spans thousands of pages.The workgroup has already reviewed Pfizer’s early-stage clinical trial data from phases 1 and 2 and found no cause for concern, Governor Gavin Newsom said. They’re still waiting to get their hands on the all-important Phase 3 data, which included thousands of participants.Panel member Dr. Rodney Hood, the president of the Multicultural Health Foundation, acknowledged the task force will have to complete its review of the Phase 3 data “very, very quickly.” Dr. Hood is one of two members from the San Diego region, along with Dr. Mark Sawyer of Rady Children’s Hospital.“We certainly don't want to introduce any unnecessary delay in the vaccine being available to Californians,” Dr. Sawyer said.The FDA has scheduled a meeting of its vaccine advisory committee, known by its acronym VRBPAC (pronounced verb-pack), on Dec. 10. The agency said it will make Pfizer’s Phase 3 data available at least two days before that meeting.At the end of that meeting, a group of about 20 experts on the advisory committee will vote on whether to recommend emergency authorization of the vaccine. The FDA is expected to issue a decision shortly after, although the agency does not have to abide by the advisory committee’s recommendation.“The California committee is on notice to be ready for a meeting either later in the day on the 10th or on December 11,” said Dr. Sawyer.Dr. Sawyer was recently added to VRBPAC, so he will cast a vote on whether to recommend approval of the vaccine at the national level before participating in California’s process.“It is going to take a few days for the vaccine to really start flowing,” he said. “I don't think the [California] committee is going to introduce extra delay.”The California committee has promised to issue its decision within 24 hours of the FDA’s to avoid slowing down distribution, but that means the members may have as few as three days to review the safety and efficacy data.Federal regulators will spend about three weeks reviewing the thousands of pages of data submitted as part of Pfizer’s application. VRBPAC and the California Scientific Safety Review Workgroup will render decisions based on summaries prepared by the FDA, Dr. Sawyer said.Both doctors say they have confidence in the FDA’s process and acknowledge it would be very unlikely for the California workgroup to break with the agency’s recommendation. They said the mission of their review is to add an extra layer of verification after complaints the Trump administration was exercising political pressure on the FDA.“I think the governor foresaw that it was going to be very important that the general community accept these vaccines, assuming they're approved and are safe and effective, because otherwise we're not going to get out of this pandemic,” Dr. Sawyer said.The doctors say they want to make sure that community acceptance extends across all demographics, so they’ll be looking closely at the numbers to see if various ethnic or racial groups had different responses to the vaccine.Based on research on past vaccines, a differential response is not expected, Dr. Hood said. However, COVID-19 does strike Latinos and African-Americans more severely, making vaccine acceptance among minority communities all the more critical.“I want to look at the data, get an assessment of risk-benefit and the question I ask is, would I take it? Number one. Number two, if I would take it, would I recommend it to my family?” he said.The doctors said they will also closely examine reports of side effects.Early data suggests both Pfizer and Moderna’s candidates have somewhat harder-hitting side effects than the typical flu vaccine. Dr. Sawyer compared the side effects to the recent shingles vaccine.“Your arm hurts for a day or two. You may not feel well. You may feel a little bit under the weather for the first 24 hours. You could even have a mild fever or headache,” he said, noting those symptoms typically resolve within 24 to 48 hours based on the data available so far.“That's actually a good sign. You want that to happen,” he added.Those sorts of short-term side effects are signs the body is building a strong immune response. They’re evidence the vaccines work as well as advertised, but the doctors say they won’t know for certain until they review the final numbers. 4949